|
ATBC Study
|
ZIA CP010195-03031
|
$1,161,432
|
$58,072
|
N/A
|
DCEG (NCI)
|
|
Preclinical analyses of advanced prostate cancer in genetically-engineered mice
|
2R01CA173481-06
|
$385,883
|
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S1
|
$120,000
|
$2,400
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S2
|
$60,000
|
$1,200
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S3
|
$118,652
|
$2,373
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S4
|
$199,541
|
$3,991
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
5P30CA013696-43
|
$3,792,720
|
$75,854
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Master Regulatory MicroRNAs in Glioblastoma
|
5U01CA220841-02
|
$452,813
|
|
ABOUNADER, ROGER
|
UNIVERSITY OF VIRGINIA
|
|
Quantitative MRI for Predicting Response of Breast Cancer to Neoadjuvant Therapy
|
5U01CA142565-10
|
$461,172
|
|
ABRAMSON, RICHARD
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Center for Multiple Myeloma Nanotherapy
|
5U54CA199092-04
|
$2,184,301
|
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
Nanoparticle mediated microenvironmental targeting of CCL3 signaling for the treatment of acute myelogenous leukemia
|
1F31CA228391-01
|
$42,418
|
|
ACKUN-FARMMER, MARIAN
|
UNIVERSITY OF ROCHESTER
|
|
Genetic identification of novel mTORC1 regulators and homeostatic signaling mechanisms
|
1F31CA228241-01
|
$44,524
|
|
ADELMANN, CHARLES
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Probing the role of the IRE1alpha-XBP1 pathway in normal and malignant hematopoiesis
|
5K22CA218467-02
|
$192,575
|
|
ADORO, STANLEY
|
CASE WESTERN RESERVE UNIVERSITY
|
|
New Roles for the WTX Tumor Suppressor and Endocytosis in WNT signaling
|
1F31CA228289-01
|
$34,190
|
|
AGAJANIAN, MEGAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cognition In Older Breast Cancer Survivors: Treatment Exposure, APOE, & Smoking
|
5R01CA172119-05
|
$661,913
|
$661,913
|
AHLES, TIM
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Cancer Prevention and Control Health Disparities Training Program
|
5T32CA078447-18
|
$161,530
|
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
A collaborative structural hub to promote Cancer Center science and drug design
|
5R50CA211440-03
|
$145,562
|
|
ALESHIN, ALEXANDER
|
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST
|
|
Modulation of wild type and mutant p53 by HMGA1
|
1F32CA221010-01A1
|
$58,654
|
|
ALEXANDER, KATHERINE
|
UNIVERSITY OF PENNSYLVANIA
|
|
Targeting Tumor Initiating Cell in Undifferentiated Pleomorphic Sarcoma
|
5R01CA183811-05
|
$435,560
|
|
ALMAN, BENJAMIN
|
DUKE UNIVERSITY
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-48S1
|
$142,498
|
$8,550
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-48
|
$2,645,581
|
$158,735
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Tumor Plasticity
|
5R35CA220446-02
|
$1,140,000
|
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
In vivo regulators of TERT promoter mutant glioblastoma
|
1F32CA228365-01
|
$58,654
|
|
AMEN, ALEXANDRA
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
Regulation of mitosis by proteolysis in yeast
|
5R01CA206157-22
|
$289,175
|
$72,294
|
AMON, ANGELIKA
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Bitter Melon Component and Colon Cancer Prevention
|
5R01CA190291-05
|
$544,710
|
|
ANANT, SHRIKANT
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
The regulation of dendritic cell function by LMYC at steady state and during immune responses to cancer
|
1F31CA228240-01
|
$30,442
|
|
ANDERSON, DAVID
|
WASHINGTON UNIVERSITY
|
|
Metro-Minnesota Community Clinical Oncology Program (MM-CCOP)
|
5UG1CA189863-06
|
$2,840,966
|
|
ANDERSON, DANIEL
|
HEALTHPARTNERS INSTITUTE
|
|
General Descriptive Studies
|
ZIA CP010183-00350
|
$521,314
|
$52,131
|
Anderson, William
|
DCEG (NCI)
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
3P30CA142543-08S1
|
$175,000
|
$1,750
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
5P30CA142543-08
|
$2,480,000
|
$24,800
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
5P30CA142543-09
|
$2,480,000
|
$49,600
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Cancer Center Support Grant
|
3P30CA082103-18S9
|
$6,765,398
|
$202,962
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18SA
|
$124,999
|
$3,750
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18SB
|
$59,999
|
$1,800
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Age and Diet: Major interacting factors that drive sporadic intestinal cancer
|
5R01CA174432-05
|
$660,173
|
$660,173
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Postdoctoral Training Program in Cancer Survivorship
|
5R25CA122061-10
|
$409,275
|
$409,275
|
AVIS, NANCY
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Understanding the role of persistent telomere cohesion in ALT cancer cells
|
1F31CA221162-01A1
|
$32,041
|
|
AZARM, KAMERON
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Translating buccal nanocytology for lung cancer screening into clinical practice
|
1R01CA225002-01A1
|
$638,469
|
|
BACKMAN, VADIM
|
NORTHWESTERN UNIVERSITY
|
|
Macrophage-Microbiota Interactions in Colon Cancer
|
1F31CA225044-01A1
|
$35,917
|
|
BADER, JACKIE
|
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
|
|
Inter-relationship between microbiota diversity, obesity and race in endometrial cancer
|
1R21CA220269-01
|
$202,928
|
$101,464
|
BAE-JUMP, VICTORIA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
University of Washington/Fred Hutch Center for AIDS Research
|
2P30AI027757-31
|
$508,801
|
|
BAETEN, JARED
|
UNIVERSITY OF WASHINGTON
|
|
Puerto Rico NCI Community Oncology Research Program Minority/Underserved
|
5UG1CA189862-05
|
$717,072
|
|
BAEZ- DIAZ, LUIS
|
COMPREHENSIVE CANCER CENTER/ UNIV/PR
|
|
Bay Area Tumor Institute NCORP
|
5UG1CA189817-05
|
$826,500
|
|
BAILEY, LISA
|
BAY AREA TUMOR INSTITUTE
|
|
Tyrosine kinase inhibitors for the treatment of childhood AML
|
5R01CA138744-09
|
$343,388
|
|
BAKER, SHARYN
|
OHIO STATE UNIVERSITY
|
|
Contribution of development and age to breast cancer etiology
|
5R01CA190980-03
|
$501,556
|
$125,389
|
BARCELLOS-HOFF, MARY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Tumor Suppression by an African Specific Variant of p53
|
1F32CA220972-01A1
|
$59,038
|
|
BARNOUD, THIBAUT
|
WISTAR INSTITUTE
|
|
Regulation of Ceramide-Based Therapeutics in Acute Myeloid Leukemia
|
5K22CA190674-03
|
$161,692
|
$53,358
|
BARTH, BRIAN
|
UNIVERSITY OF NEW HAMPSHIRE
|
|
Regulation of Ceramide-Based Therapeutics in Acute Myeloid Leukemia
|
5K22CA190674-04
|
$161,692
|
$53,358
|
BARTH, BRIAN
|
UNIVERSITY OF NEW HAMPSHIRE
|
|
Early detection of ovarian cancer by serum marker and targeted ultrasound imaging
|
5R01CA210370-03
|
$356,233
|
|
BARUA, ANIMESH
|
RUSH UNIVERSITY MEDICAL CENTER
|
|
Therapeutic targeting of Fibroblast Growth Factor Receptors in Squamous Cancers
|
5R01CA196932-04
|
$387,027
|
|
BASS, ADAM
|
DANA-FARBER CANCER INST
|
Total relevant funding to Aging for this search: $58,527,694
|